Undertreatment of women with lipid-lowering therapies in four European countries: results from the prospective, non-interventional MILOS Study

30 August 2025 (09:09 - 09:27)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor Ioanna Gouni-Berthold

University of Cologne, Cologne (Germany)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Professor D. Bhatt (New York City, US)

Presentation thumbnail

Impact of oral semaglutide on cardiovascular risk factors in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: a SOUL post hoc analysis

Professor S. Mulvagh (Halifax, CA)

Abstract Slides Video

Presentation thumbnail

Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHF

Doctor R. Aggarwal (Boston, US)

Abstract Slides Video

Presentation thumbnail

Effects of icosapent ethyl on risk and duration of hospitalizations and death in REDUCE-IT

Doctor D. Bhatt (New York City, US)

Abstract Slides Video

Access the full session

Session thumbnail

Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

The Event

Event poster

ESC Congress 2025

30 August 2025 09:09 CET

You may be interested in

Congress Presentation

Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study

Congress Session

Refining efficacy and safety of lipid-lowering pharmacotherapy

Congress Session

Changing face of lipid-lowering therapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources